ATE393631T1 - Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen - Google Patents

Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen

Info

Publication number
ATE393631T1
ATE393631T1 AT02767552T AT02767552T ATE393631T1 AT E393631 T1 ATE393631 T1 AT E393631T1 AT 02767552 T AT02767552 T AT 02767552T AT 02767552 T AT02767552 T AT 02767552T AT E393631 T1 ATE393631 T1 AT E393631T1
Authority
AT
Austria
Prior art keywords
cosmetic
peptide
skin cells
improve adhesion
dermatological use
Prior art date
Application number
AT02767552T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Original Assignee
Soc Extraction Principes Actif
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif filed Critical Soc Extraction Principes Actif
Application granted granted Critical
Publication of ATE393631T1 publication Critical patent/ATE393631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT02767552T 2001-07-13 2002-07-08 Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen ATE393631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109361A FR2827174B1 (fr) 2001-07-13 2001-07-13 Utilisation de peptides pour augmenter l'adhesion cellulaire

Publications (1)

Publication Number Publication Date
ATE393631T1 true ATE393631T1 (de) 2008-05-15

Family

ID=8865473

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02767552T ATE393631T1 (de) 2001-07-13 2002-07-08 Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen

Country Status (7)

Country Link
US (1) US20040141939A1 (de)
EP (1) EP1406651B1 (de)
AT (1) ATE393631T1 (de)
AU (1) AU2002330555A1 (de)
DE (1) DE60226323D1 (de)
FR (1) FR2827174B1 (de)
WO (1) WO2003008438A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080095732A1 (en) * 2005-04-27 2008-04-24 Rosemarie Osborne Personal care compositions
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
AU2014271339B2 (en) * 2005-04-27 2016-11-03 The Procter & Gamble Company Personal care compositions
FR2893502A1 (fr) 2005-11-21 2007-05-25 Oreal Procede cosmetique de soin de la peau utilisant des contraintes mecaniques
FR2893501B1 (fr) * 2005-11-21 2014-03-14 Oreal Compositions topiques pour favoriser l'homeostasie de la peau
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
FR2940291B1 (fr) 2008-12-23 2012-12-21 Isp Investments Inc Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant
FR2940125B1 (fr) 2008-12-23 2013-03-22 Isp Investments Inc Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
FR2944526B1 (fr) 2009-04-15 2013-05-10 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
FR2944445B1 (fr) 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944446B1 (fr) * 2009-04-15 2013-08-16 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
US20110052676A1 (en) * 2009-09-01 2011-03-03 James Vincent Gruber Composition For Delaying Cellular Senescence
CN104072582B (zh) * 2013-03-27 2020-07-28 乐敦制药株式会社 新型肽
US9005674B1 (en) 2013-07-01 2015-04-14 The Procter & Gamble Company Method of improving the appearance of aging skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61238712A (ja) * 1985-04-17 1986-10-24 Shiseido Co Ltd 皮膚化粧料
US5821231A (en) * 1993-12-06 1998-10-13 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using same
US6479258B1 (en) * 1995-12-07 2002-11-12 Diversa Corporation Non-stochastic generation of genetic vaccines
WO2000077042A2 (en) * 1999-06-15 2000-12-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Parathyroid hormone receptor ligands
WO2001043774A1 (en) * 1999-12-16 2001-06-21 Biogen, Inc. Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists

Also Published As

Publication number Publication date
WO2003008438A2 (fr) 2003-01-30
EP1406651A2 (de) 2004-04-14
FR2827174B1 (fr) 2004-08-06
FR2827174A1 (fr) 2003-01-17
AU2002330555A1 (en) 2003-03-03
DE60226323D1 (de) 2008-06-12
WO2003008438A3 (fr) 2004-02-12
US20040141939A1 (en) 2004-07-22
EP1406651B1 (de) 2008-04-30

Similar Documents

Publication Publication Date Title
ATE393631T1 (de) Peptid und dessen kosmetische oder dermatologische verwendung zur verbesserung der haftung zwischen hautzellen
WO2003007905A3 (fr) Utilisation cosmetique ou dermatologique de peptides pour augmenter l'adhesion entre les cellules cutanees
US10844101B2 (en) Plant-derived elastin binding protein ligands and methods of using the same
MX361694B (es) Fragmentos de peptidos para inducir sintesis de proteinas de matriz extra-celular.
ES2285859T3 (es) Utilizacion cosmetica o dermofarmaceutica de peptidos para la cicatrizacion, la hidratacion y la mejora del aspecto cutaneo durante el envejecimiento natural o acelerado (heliodermia, contaminacion).
ATE494902T1 (de) Ein huhn gnrh-ii analog zur verwendung in der reduktion des tumorzellwachstums
ATE326243T1 (de) Methoden zur verbesserung der vaskularisierung und förderung der wundheilung
ATE291416T1 (de) Topische zusammensetzungen zur erhöhung der glutathion produktion
WO2004073616A3 (en) Elastin digest compositions and methods utilizing same
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
KR101504893B1 (ko) 인터루킨-1 알파 및 펩티드를 함유하는 화장료 조성물
GB0016189D0 (en) Cosmetic composition
PT1390007E (pt) Composição cosmética à base de sucralfato e de sulfatos de cobre e de zinco
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
WO2025185523A8 (zh) 环肽及其组合物和用途
WO2003066814A3 (en) Peptide-dependent upregulation of telomerase expression
WO1998004280A3 (en) Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
CN1966516A (zh) 纳米胶原寡肽及其制备方法
ATE510008T1 (de) Entzündungshemmende peptide
NZ591825A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
DE59503776D1 (de) Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung
GB0209384D0 (en) Peptide composition
CN115785257A (zh) 一种基于大鲵水解胶原的十五肽及其应用
SE0700513L (sv) Kosmetiska kompositioner
CN121800879A (zh) 一种环七肽及其制备方法和应用

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties